American Vanguard (AVD) 10-Q12 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2024	Nov. 04, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Trading Symbol	AVD
Entity Registrant Name	AMERICAN VANGUARD CORPORATION
Entity Central Index Key	0000005981
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		28,787,829
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity File Number	001-13795
Entity Tax Identification Number	95-2588080
Entity Address, Address Line One	4695 MacArthur Court
Entity Address, City or Town	Newport Beach
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92660
City Area Code	949
Local Phone Number	260-1200
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock, $.10 par value
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	DE

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net sales	$ 118,307	$ 149,516	$ 381,659	$ 407,191
Cost of sales	(101,014)	(106,432)	(284,185)	(282,662)
Gross profit	17,293	43,084	97,474	124,529
Operating expenses
Selling, general and administrative	(26,365)	(29,813)	(86,885)	(85,954)
Research, product development and regulatory	(11,177)	(9,080)	(25,482)	(27,363)
Transformation	(8,139)	0	(16,636)	0
Operating (loss) income	(28,388)	4,191	(31,529)	11,212
Change in fair value of equity investments	0	(247)	513	(324)
Interest expense, net	(4,378)	(3,384)	(11,988)	(8,282)
(Loss) income before provision for income taxes	(32,766)	560	(43,004)	2,606
Income tax benefit (expense)	7,024	(885)	7,093	(2,066)
Net (loss) income	$ (25,742)	$ (325)	$ (35,911)	$ 540
Net (loss) income per common share-basic	$ (0.91)	$ (0.01)	$ (1.28)	$ 0.02
Net (loss) income per common share-assuming dilution	$ (0.91)	$ (0.01)	$ (1.28)	$ 0.02
Weighted average shares outstanding-basic	28,173	27,919	28,015	28,236
Weighted average shares outstanding-assuming dilution	28,173	27,919	28,015	28,656

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (25,742)	$ (325)	$ (35,911)	$ 540
Other comprehensive (loss) income:
Foreign currency translation adjustment, net of tax effects	(593)	(3,123)	(7,886)	2,928
Comprehensive (loss) income	$ (26,335)	$ (3,448)	$ (43,797)	$ 3,468

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 11,880	$ 11,416
Receivables:
Trade, net of allowance for credit losses of $8,661 and $7,107, respectively	146,145	182,613
Other	5,852	8,356
Total receivables, net	151,997	190,969
Inventories	246,037	219,551
Prepaid expenses	7,501	6,261
Income taxes receivable	7,690	3,824
Total current assets	425,105	432,021
Property, plant and equipment, net	73,494	74,560
Operating lease right-of-use assets, net	21,448	22,417
Intangible assets, net of amortization	164,480	172,508
Goodwill	48,012	51,199
Deferred income tax assets	12,218	2,849
Other assets	14,701	11,994
Total assets	759,458	767,548
Current liabilities:
Accounts payable	73,557	68,833
Customer prepayments	27,183	65,560
Accrued program costs	85,665	68,076
Accrued expenses and other payables	29,066	16,354
Operating lease liabilities, current	6,604	6,081
Income taxes payable	3,229	5,591
Total current liabilities	225,304	230,495
Long-term debt	178,749	138,900
Long-term operating lease liabilities	15,574	17,113
Other liabilities, net of current installments	2,756	3,138
Deferred income tax liabilities, net	9,167	7,892
Total liabilities	431,550	397,538
Commitments and contingent liabilities (Note 12)
Stockholders' equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued	0	0
Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,525,983 shares at September 30, 2024 and 34,676,787 shares at December 31, 2023	3,452	3,467
Additional paid-in capital	114,196	110,810
Accumulated other comprehensive loss	(13,849)	(5,963)
Retained earnings	295,310	332,897
Less treasury stock at cost, 5,915,182 shares at September 30, 2024 and December 31, 2023	(71,201)	(71,201)
Total stockholders’ equity	327,908	370,010
Total liabilities and stockholders' equity	$ 759,458	$ 767,548

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 8,661	$ 7,107
Preferred stock, par value per share	$ 0.10	$ 0.10
Preferred stock, shares authorized	400,000	400,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.10	$ 0.10
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	34,525,983	34,676,787
Treasury Stock, Common shares	5,915,182	5,915,182

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Treasury Stock
Balance at Dec. 31, 2022	$ 369,979	$ 3,444	$ 105,634	$ (12,182)	$ 328,745	$ (55,662)
Balance (in shares) at Dec. 31, 2022		34,446,194				5,029,892
Common stock issued under ESPP	480	$ 2	478
Common stock issued under ESPP, (in Shares)		22,101
Cash dividends on common stock declared	(851)				(851)
Foreign currency translation adjustment, net	2,546			2,546
Stock-based compensation	1,474		1,474
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)	5		5
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares		(4,466)
Shares repurchased	(557)					$ (557)
Shares repurchased (In Shares)						27,835
Net (loss) income	1,918				1,918
Balance at Mar. 31, 2023	374,994	$ 3,446	107,591	(9,636)	329,812	$ (56,219)
Balance (in shares) at Mar. 31, 2023		34,463,829				5,057,727
Balance at Dec. 31, 2022	369,979	$ 3,444	105,634	(12,182)	328,745	$ (55,662)
Balance (in shares) at Dec. 31, 2022		34,446,194				5,029,892
Foreign currency translation adjustment, net	2,928
Net (loss) income	540
Balance at Sep. 30, 2023	358,701	$ 3,467	108,937	(9,254)	326,752	$ (71,201)
Balance (in shares) at Sep. 30, 2023		34,666,431				5,915,182
Balance at Mar. 31, 2023	374,994	$ 3,446	107,591	(9,636)	329,812	$ (56,219)
Balance (in shares) at Mar. 31, 2023		34,463,829				5,057,727
Cash dividends on common stock declared	(848)				(848)
Foreign currency translation adjustment, net	3,505			3,505
Stock-based compensation	1,067		1,067
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)	(1,921)	$ 18	(1,939)
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares		179,845
Shares repurchased	(6,669)					$ (6,669)
Shares repurchased (In Shares)						380,366
Net (loss) income	(1,053)				(1,053)	$ 0
Balance at Jun. 30, 2023	369,075	$ 3,464	106,719	(6,131)	327,911	$ (62,888)
Balance (in shares) at Jun. 30, 2023		34,643,674				5,438,093
Common stock issued under ESPP	500	$ 3	497
Common stock issued under ESPP, (in Shares)		27,924
Cash dividends on common stock declared	(834)				(834)
Foreign currency translation adjustment, net	(3,123)			(3,123)
Stock-based compensation	1,716		1,716
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)	5		5
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares		(5,167)
Shares repurchased	(8,313)					$ (8,313)
Shares repurchased (In Shares)						477,089
Net (loss) income	(325)				(325)
Balance at Sep. 30, 2023	358,701	$ 3,467	108,937	(9,254)	326,752	$ (71,201)
Balance (in shares) at Sep. 30, 2023		34,666,431				5,915,182
Balance at Dec. 31, 2023	$ 370,010	$ 3,467	110,810	(5,963)	332,897	$ (71,201)
Balance (in shares) at Dec. 31, 2023	34,676,787	34,676,787				5,915,182
Common stock issued under ESPP	$ 430	$ 4	426
Common stock issued under ESPP, (in Shares)		38,702
Cash dividends on common stock declared	(836)				(836)
Foreign currency translation adjustment, net	(1,564)			(1,564)
Stock-based compensation	2,005		2,005
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)	(14)	$ 4	(18)
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares		39,145
Net (loss) income	1,552				1,552
Balance at Mar. 31, 2024	371,583	$ 3,475	113,223	(7,527)	333,613	$ (71,201)
Balance (in shares) at Mar. 31, 2024		34,754,634				5,915,182
Balance at Dec. 31, 2023	$ 370,010	$ 3,467	110,810	(5,963)	332,897	$ (71,201)
Balance (in shares) at Dec. 31, 2023	34,676,787	34,676,787				5,915,182
Foreign currency translation adjustment, net	$ (7,886)
Net (loss) income	(35,911)
Balance at Sep. 30, 2024	$ 327,908	$ 3,452	114,196	(13,849)	295,310	$ (71,201)
Balance (in shares) at Sep. 30, 2024	34,525,983	34,525,983				5,915,182
Balance at Mar. 31, 2024	$ 371,583	$ 3,475	113,223	(7,527)	333,613	$ (71,201)
Balance (in shares) at Mar. 31, 2024		34,754,634				5,915,182
Cash dividends on common stock declared	(840)				(840)
Foreign currency translation adjustment, net	(5,729)			(5,729)
Stock-based compensation	747		747
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)	(815)	$ (10)	(805)
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares		(99,205)
Net (loss) income	(11,721)			0	(11,721)
Balance at Jun. 30, 2024	353,225	$ 3,465	113,165	(13,256)	321,052	$ (71,201)
Balance (in shares) at Jun. 30, 2024		34,655,429				5,915,182
Common stock issued under ESPP	471	$ 6	465
Common stock issued under ESPP, (in Shares)		54,065
Foreign currency translation adjustment, net	(593)			(593)
Stock-based compensation	1,135		1,135
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes)	(588)	$ (19)	(569)	0
Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes), Shares		(183,511)
Net (loss) income	(25,742)				(25,742)
Balance at Sep. 30, 2024	$ 327,908	$ 3,452	$ 114,196	$ (13,849)	$ 295,310	$ (71,201)
Balance (in shares) at Sep. 30, 2024	34,525,983	34,525,983				5,915,182

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]
Cash dividends on common stock, per share	$ 0.03	$ 0.03	$ 0.03	$ 0.03	$ 0.03

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net (loss) income	$ (35,911)	$ 540
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation of property, plant and equipment	6,655	6,396
Amortization of intangibles assets	9,947	10,009
Amortization of other long-term assets	199	1,445
Amortization of deferred loan fees	342	174
Provision for bad debts	1,278	952
Stock-based compensation	3,887	4,257
Change in deferred income taxes	(9,110)	(977)
Changes in liabilities for uncertain tax positions or unrecognized tax benefits	106	467
Change in equity investment fair value	(513)	324
Other	110	7
Foreign currency transaction losses	121	199
Changes in assets and liabilities associated with operations:
Decrease (increase) in net receivables	33,475	(29,055)
Increase in inventories	(29,429)	(58,163)
Increase in prepaid expenses and other assets	(4,107)	(633)
Change in income tax receivable/payable, net	(6,216)	(4,046)
Increase (decrease) in net operating lease liability	(48)	227
Increase in accounts payable	6,141	1,240
Decrease in customer prepayments	(38,375)	(104,590)
Increase in accrued program costs	17,721	29,779
Increase (decrease) in other payables and accrued expenses	13,878	(4,406)
Net cash used in operating activities	(29,849)	(145,854)
Cash flows from investing activities:
Capital expenditures	(6,106)	(8,589)
Proceeds from disposal of property, plant and equipment	66	200
Intangible assets	(341)	(759)
Net cash used in investing activities	(6,381)	(9,148)
Cash flows from financing activities:
Payments under line of credit agreement	(168,188)	(62,800)
Borrowings under line of credit agreement	208,037	228,500
Receipt from the issuance of common stock under ESPP	901	980
Net receipt from the exercise of stock options	0	46
Net payment for tax withholding on stock-based compensation awards	(1,416)	(1,957)
Repurchase of common stock	0	(15,539)
Payment of cash dividends	(2,510)	(2,550)
Net cash provided by financing activities	36,824	146,680
Net increase (decrease) in cash and cash equivalents	594	(8,322)
Effect of exchange rate changes on cash and cash equivalents	(130)	(477)
Cash and cash equivalents at beginning of period	11,416	20,328
Cash and cash equivalents at end of period	$ 11,880	$ 11,529

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (25,742)	$ (325)	$ (35,911)	$ 540

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies — The accompanying unaudited condensed consolidated financial statements of American Vanguard Corporation and Subsidiaries (“AVD” or “the Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of consolidating adjustments, eliminations and normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. The condensed consolidated financial statements and related notes do not include all information and footnotes required by US GAAP for annual reports. This quarterly report should be read in conjunction with the consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2023. All significant accounting policies used in the preparation of these condensed consolidated financial statements are consistent with those disclosed in the Company's Annual Report on Form 10-K except for the following: Transformation Transformation expenses on the condensed consolidated statements of operations include costs related to the Company’s digital and structural transformation project. The digital transformation effort is intended to ensure that business process owners have access to current and complete data that has been generated through standardized systems and processes. The structural transformation effort is intended to improve operating leverage by applying business analytics to current operations, structures, products and services and identifying process improvements. Transformation expenses primarily include costs for consulting services, severance costs, and other costs which were incurred in connection with the staffing and execution of the Company’s various transformation initiatives .

Leases

Leases	9 Months Ended
Leases	Sep. 30, 2024
Leases [Abstract]
Leases	2. Leases — The Company has operating leases for warehouses, manufacturing facilities, offices, cars, railcars and certain equipment. The lease term includes the non-cancellable period of the lease plus any additional periods covered by either an option to extend (or not terminate) that the Company is reasonably certain to exercise. The Company has leases with a lease term ranging from one year to approximately 20 years. The operating lease expense for the three months ended September 30, 2024 and 2023, was $ 1,972 and $ 1,701 , respectively, and $ 5,863 and $ 5,012 for the nine months ended September 30, 2024 and 2023, respectively. Lease expenses related to variable lease payments and short-term leases were immaterial. Other information related to operating leases follows: Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cash paid for amounts included in the $ 1,956 $ 1,601 $ 5,909 $ 4,788 ROU assets obtained in exchange for $ 541 $ 643 $ 4,211 $ 3,220 The weighted-average remaining lease term and discount rate related to the operating leases as of September 30, 2024 were as follows: Weighted-average remaining lease term (in years) 4.55 Weighted-average discount rate 4.94 % Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows: 2024 (excluding nine months ended September 30, 2024) $ 1,950 2025 7,078 2026 5,202 2027 3,451 2028 2,339 Thereafter 4,676 Total lease payments 24,696 Less: imputed interest ( 2,518 ) Total $ 22,178 Amounts recognized in the condensed consolidated balance sheets at September 30, 2024: Operating lease liabilities, current $ 6,604 Operating lease liabilities, long-term $ 15,574

Revenue Recognition

Revenue Recognition	9 Months Ended
Revenue Recognition	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	3. Revenue Recognition —The Company recognizes revenue from the sale of its products, which include crop and non-crop products. The Company sells its products to customers, which include distributors, retailers, and growers. In addition, the Company recognizes royalty income from licensing agreements. Substantially all revenue is recognized at a point in time. During the three and nine months ended September 30, 2024, the Company recorded a reduction to sales in the amount of $ 11,783 related to the U.S. Crop business and $ 620 related to the international businesses in connection with the Company's voluntarily recall of the Dacthal product line. These amounts are based on estimated return claims from retailers and growers. The Company has one reportable segment. Selective enterprise information of sales disaggregated by category and geographic region is as follows: For the Three Months Ended September 30, 2024 2023 Change % Change Net sales: U.S. crop $ 35,533 $ 67,749 $ ( 32,216 ) - 48 % U.S. non-crop 22,454 19,250 3,204 17 % Total U.S. 57,987 86,999 ( 29,012 ) - 33 % International 60,320 62,517 ( 2,197 ) - 4 % Total net sales $ 118,307 $ 149,516 $ ( 31,209 ) - 21 % For the Nine Months Ended September 30, 2024 2023 Change % Change Net sales: U.S. crop $ 155,075 $ 185,823 $ ( 30,748 ) - 17 % U.S. non-crop 59,241 50,041 9,200 18 % Total U.S. 214,316 235,864 ( 21,548 ) - 9 % International 167,343 171,327 ( 3,984 ) - 2 % Total net sales $ 381,659 $ 407,191 $ ( 25,532 ) - 6 % The Company sometimes receives payments from its customers in advance of goods and services being provided in return for early cash incentive programs. These payments are included in customer prepayments on the condensed consolidated balance sheets. Revenue recognized for the three and nine months ended September 30, 2024, that was included in customer prepayments at the beginning of 2024, was $ 12,042 and $ 65,512 , respectively. The remaining balance of those customer prepayments from the start of 2024 in the amount of $ 48 is expected to be recognized as revenue in fiscal 2024. During the three months ended September 30, 2024, the Company received customer prepayments in the amount of $ 57,000 that are expected to be recognized as revenue during the 2024-2025 growing season in the United States, which began on September 1, 2024.

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
Property, Plant and Equipment	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	4. Property, Plant and Equipment — Property, plant and equipment at September 30, 2024 and December 31, 2023 consists of the following: September 30, December 31, 2023 Land $ 2,757 $ 2,765 Buildings and improvements 21,131 21,088 Machinery and equipment 155,633 148,912 Office furniture, fixtures and equipment 12,529 10,622 Automotive equipment 1,043 1,247 Construction in progress 6,505 10,553 Total gross value 199,598 195,187 Less accumulated depreciation ( 126,104 ) ( 120,627 ) Total net value $ 73,494 $ 74,560 The Company recognized depreciation expense related to property and equipment of $ 2,290 and $ 2,074 for the three-month periods ended September 30, 2024 and 2023, respectively. The Company recognized depreciation expense related to property and equipment of $ 6,655 and $ 6,396 for the nine months ended September 30, 2024 and 2023, respectively. Substantially all of the Company’s assets are pledged as collateral to its banks.

Inventories

Inventories	9 Months Ended
Inventories	Sep. 30, 2024
Inventory Disclosure [Abstract]
Inventories	5. Inventories —Inventory is stated at the lower of cost or net realizable value. Cost is determined by the average cost method, and includes material, labor, factory overhead and subcontracting services. September 30, December 31, 2023 Finished products $ 201,227 $ 198,935 Raw materials 44,810 20,616 Total inventories $ 246,037 $ 219,551 Finished products consist of products that are sold to customers in their current form as well as intermediate products that require further formulation to be saleable to customers.

Accrued Program Costs

Accrued Program Costs	9 Months Ended
Accrued Program Costs	Sep. 30, 2024
Payables and Accruals [Abstract]
Accrued Program Costs	6. Accrued Program Costs — The Company offers various discounts to customers based on the volume purchased within a defined period, other pricing adjustments, some grower volume incentives or other key performance indicator driven payments made to distributors, retailers or growers, usually at the end of a growing season. The Company describes these payments as “Programs.” Programs are a critical part of doing business in both the U.S. crop and non-crop chemicals marketplaces. These discount Programs represent variable consideration. Revenues from sales are recorded at the net sales price, which is the transaction price, less an estimate of variable consideration. Variable consideration includes amounts expected to be paid to its customers using the expected value method. Each quarter management compares individual sale transactions with Programs to determine what, if any, Program liabilities have been incurred. Once this initial calculation is made for the specific quarter, sales and marketing management, along with executive and financial management, review the accumulated Program balance and, for volume driven payments, make assessments of whether or not customers are tracking in a manner that indicates that they will meet the requirements set out in agreed upon terms and conditions attached to each Program. Following this assessment, management adjusts the accumulated accrual to properly reflect the liability at the balance sheet date. Programs are paid out predominantly on an annual basis, usually in the final quarter of the financial year or the first quarter of the following year.

Cash Dividends on Common Stock

Cash Dividends on Common Stock	9 Months Ended
Cash Dividends on Common Stock	Sep. 30, 2024
Cash Dividends [Abstract]
Cash Dividends on Common Stock	7. Cash Dividends on Common Stock — The Company has declared and paid the following cash dividends in the periods covered by this Form 10-Q: Declaration Date Record Date Distribution Date Dividend Total June 10, 2024 June 26, 2024 July 10, 2024 $ 0.030 $ 840 March 11, 2024 March 27, 2024 April 10, 2024 $ 0.030 $ 836 December 15, 2023 December 29, 2023 January 12, 2024 $ 0.030 $ 834 September 12, 2023 September 22, 2023 October 6, 2023 $ 0.030 $ 834 June 12, 2023 June 28, 2023 July 14, 2023 $ 0.030 $ 848 March 13, 2023 March 24, 2023 April 14, 2023 $ 0.030 $ 851 December 13, 2022 December 28, 2022 January 11, 2023 $ 0.030 $ 851

Earnings Per Share

Earnings Per Share	9 Months Ended
Earnings Per Share	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share	8. Earnings Per Share — The components of basic and diluted net (loss) income per share were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net (loss) income $ ( 25,742 ) $ ( 325 ) $ ( 35,911 ) $ 540 Denominator: (in thousands) Weighted average shares outstanding-basic 28,173 27,919 28,015 28,236 Dilutive effect of stock options and grants — — — 420 Weighted average shares outstanding-diluted 28,173 27,919 28,015 28,656 Due to a net loss for the three- and nine- month periods ended September 30, 2024 and for the three-month period ended September 30, 2023, stock options and other grants were excluded from the computation of diluted net loss per share. For the nine-month period ended September 30, 2023, no stock options were excluded from the computation of diluted net income per share.

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2024
Debt Disclosure [Abstract]
Debt	9. Debt — The Company has a revolving line of credit that is shown as long-term debt in the condensed consolidated balance sheets at September 30, 2024 and December 31, 2023. The Company has no short-term debt as of September 30, 2024 and December 31, 2023. The debt is summarized in the following table: Long-term indebtedness ($000's) September 30, 2024 December 31, 2023 Revolving line of credit $ 178,749 $ 138,900 Deferred loan fees ( 1,726 ) ( 1,218 ) Total indebtedness, net of deferred loan fees $ 177,023 $ 137,682 The deferred loan fees as of September 30, 2024 and December 31, 2023 are included in other assets on the condensed consolidated balance sheets. The Company and certain of its affiliates are parties to a revolving line of credit agreement entitled the “Third Amended and Restated Loan and Security Agreement” dated as of August 5, 2021 (the “Credit Agreement”), which is a senior secured lending facility among AMVAC, the Company’s principal operating subsidiary, as Borrower Agent (including the Company and AMVAC BV), as Borrowers, on the one hand, and a group of commercial lenders led by Bank of the West as administrative agent, documentation agent, syndication agent, collateral agent and sole lead arranger, on the other hand. The Credit Agreement consists of a line of credit of up to $ 275,000 , an accordion feature of up to $ 150,000 , a letter of credit and swingline sub-facility (each having limits of $ 25,000 ) and has a maturity date of August 5, 2026 . With respect to key financial covenants, the Credit Agreement originally contained two: namely, borrowers are required to maintain a Total Leverage Ratio of no more than 3.5 -to-1, during the first three years, stepping down to 3.25 -to-1 as of September 30, 2024, and a Fixed Charge Coverage Ratio of at least 1.25 -to-1. In addition, to the extent that it completes acquisitions totaling $ 15,000 or more in any 90-day period, AMVAC may step-up the Total Leverage Ratio by 0.5 -to-1, not to exceed 4.00 -to-1, for the next three full consecutive quarters. Acquisitions below $ 50,000 do not require Agent consent. On August 8, 2024, the Company and the lenders entered into Amendment Number Seven to the Credit Agreement, effective June 30, 2024, under which the Maximum Total Leverage Ratio was modified to 4.25 for the period ended June 30, 2024; 5.0 for the period ending September 30, 2024; 4.5 for the periods ending December 31, 2024, March 31, 2025 and 4.25 for June 30, 2025; 4.0 for the period ending September 30, 2025, and returning to 3.25 for the period ending December 31, 2025 and thereafter. The Minimum Fixed Charge Coverage Ratio remains the same, and a new covenant, the Minimum Modified Current Ratio of not less than 1.5 (defined as the ratio of (i) Accounts Receivable plus Inventory, to (ii) Funded Debt of the Company and its Subsidiaries on a consolidated basis). In addition, the Company may not repurchase shares, pay cash dividends to shareholders or make Permitted Acquisitions without Lenders’ consent. In addition, for purposes of calculating Consolidated EBITDA, the basket for transformation and one-time (cash and non-cash charges (which are excluded from such measure) has been increased from $5,000 to $12,500 in second quarter 2024, $45,000 (in third quarter 2024, fourth quarter 2024 and first quarter 2025), $42,500 in second quarter 2025, $15,000 in third quarter 2025 and $7,500 in fourth quarter 2025, as measured on a four-quarter trailing basis. Finally, the interest rates for the Credit Agreement, as amended, were increased by 25bps to the extent the Total Leverage Ratio equals or exceeds 4.0 and remains at the rates set forth in the Amendment Number Six to the extent the Total Leverage Ratio is below 4.0 . The Company’s borrowing capacity varies with its financial performance, measured in terms of Consolidated EBITDA as defined in the Credit Agreement, for the trailing twelve-month period. Under the Credit Agreement, revolving loans bear interest at a variable rate based, at borrower’s election with proper notice, on either (i) LIBOR plus the “Applicable Margin” which is based upon the Total Leverage Ratio (“LIBOR Revolver Loan”) or (ii) the greater of (x) the Prime Rate, (y) the Federal Funds Rate plus 0.5 %, and (z) the Daily One-Month LIBOR Rate plus 1.00 %, plus, in the case of (x), (y) or (z) the Applicable Margin (“Adjusted Base Rate Revolver Loan”). The Company and the Lenders entered into an amendment to the Credit Agreement, effective March 9, 2023, whereby LIBOR was replaced by SOFR with a credit spread adjustment of 10.0 bps for all SOFR periods. The revolving loans now bear interest at a variable rate based at our election with proper notice, on either (i) SOFR plus 0.1% per annum and the “Applicable Margin” or (ii) the greater of (x) the Prime Rate, (y) the Federal Funds Rate plus 0.5 %, and (z) the Daily One-Month SOFR Rate plus 1.10 %, plus, in the case of (x), (y) or (z) the Applicable Margin (“Adjusted Base Rate Revolver Loan”). Interest payments for SOFR Revolver Loans are payable on the last day of each interest period (either one-, three- or nine- month periods, as selected by the Company) and the maturity date, while interest payments for Adjusted Base Rate Revolver Loans are payable on the last business day of each month and the maturity date. The interest rate on September 30, 2024, was 8.48 %. Interest was $ 4,435 and $ 3,384 for the three months ended September 30, 2024 and 2023, respectively, and $ 12,296 and $ 8,282 for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024, the Company is deemed to be in compliance with its financial covenants. Furthermore, according to the terms of the Credit Agreement, as amended, and based on our performance against the most restrictive covenant listed above, the Company had the capacity to increase its borrowings by up to $ 44,716 and $ 115,002 as of September 30, 2024 and December 31, 2023, respectively.

Comprehensive (Loss) Income

Comprehensive (Loss) Income	9 Months Ended
Comprehensive (Loss) Income	Sep. 30, 2024
Equity [Abstract]
Comprehensive (Loss) Income	10. Comprehensive (Loss) Income — Total comprehensive (loss) income includes, in addition to net (loss) income, changes in equity that are excluded from the condensed consolidated statements of operations and are recorded directly into a separate section of stockholders’ equity on the condensed consolidated balance sheets. For the three- and nine-month periods ended September 30, 2024 and 2023, total comprehensive (loss) income consisted of net (loss) income and foreign currency translation adjustments.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
Stock Based Compensation	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation	11. Stock-Based Compensation — Under the Company’s Equity Incentive Plan of 1993, as amended (“the Plan”), all employees are eligible to receive non-assignable and non-transferable restricted stock (RSUs), options to purchase common stock, and other forms of equity. During the three months ended September 30, 2024 and 2023, the Company's stock-based compensation expense amounted to $ 1,135 and $ 1,716 , respectively. During the nine months ended September 30, 2024 and 2023, the Company's stock-based compensation expense amounted to $ 3,887 and $ 4,257 , respectively. RSUs A summary of nonvested RSUs outstanding is presented below: Nine Months Ended Number Weighted Nonvested shares at January 1, 2024 949,510 $ 21.28 Granted 58,573 10.39 Vested ( 403,038 ) 20.40 Forfeited ( 178,338 ) 20.05 Nonvested shares at September 30, 2024 426,707 $ 21.13 As of September 30, 2024, the total unrecognized stock-based compensation expense related to RSUs outstanding was $ 3,278 and is expected to be recognized over a weighted-average period of 1.3 years. Stock Options A summary of the time-based incentive stock option activity for the nine months ended September 30, 2024 is presented below: Options outstanding Weighted Average Exercise Price Per Share Weighted Average Remaining Contractual Life (Years) Aggregate Intrinsic Value Balance as of January 1, 2024 146,680 $ 11.49 1.0 $ — Granted 680,737 $ 10.29 6.3 $ — Forfeited ( 232,229 ) $ 10.32 6.3 $ — Balance as of September 30, 2024 595,188 $ 10.58 5.6 $ — Options vested and exercisable as of September 30, 2024 203,542 $ 11.15 1.9 $ — As of September 30, 2024, the total unrecognized stock-based compensation expense related to stock options outstanding was $ 1,209 and is expected to be recognized over a weighted-average period of 2.3 years.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies — The Company records a liability on its consolidated financial statements for loss contingencies when a loss is known or considered probable, and the amount can be reasonably estimated. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. The Company recognizes legal expenses in connection with loss contingencies as incurred. Department of Justice and Environmental Protection Agency Investigation . On November 10, 2016, AMVAC was served with a grand jury subpoena from the United States Attorney’s Office for the Southern District of Alabama, seeking documents regarding the importation, transportation, and management of a specific pesticide. The Company retained defense counsel to assist in responding to the subpoena and otherwise in defending the Company’s interests. AMVAC fully cooperated during the investigation. After interviewing multiple witnesses (including three employees before a grand jury in February 2022) and making multiple document requests, the Department of Justice (“DoJ”) identified the Company and a manager-level employee as targets of the government’s investigation. DoJ’s investigation focused on potential violations of two environmental statutes, the Federal Insecticide, Fungicide, and Rodenticide Act (“FIFRA”) and the Resource Conservation and Recovery Act (“RCRA”), as well as obstruction of an agency proceeding and false statement statutes. In March 2022, the individual target entered into a plea agreement relating to provision of false information in a government proceeding. In January 2024, the Company and DoJ reached an agreement in principle, subject to approval by the cognizant court and with respect to which the Company has recorded a loss contingency. A Company representative attended a hearing to enter a plea of guilty (to one count of transporting hazardous waste without a waste manifest) on the matter in late May 2024. Under the terms of the plea agreement, the Company would pay a fine and enter into a three-year probation during which it would be subject to an environmental compliance plan. The court provisionally accepted the plea, subject to entry of an order following a sentencing hearing on October 25, 2024, on which date the court accepted with finality the plea and entered a sentence as per the plea agreement. At that time, the Company paid a monetary fine, with respect to which a liability had been recorded during the quarter ended December 31, 2023. Reyes v. AMVAC . On September 28, 2023, the Company received correspondence from counsel for ex-employee Jorge Reyes Jr. addressed to the California Department of Industrial Relations alleging a number of wage and hour violations under California law. This is a precursor to a civil filing under applicable state law. Subsequently, plaintiff, putatively on behalf of the class of similarly situated, non-exempt California-based employees, served a summons and complaint on the Company’s registered agent that had been electronically filed as Case No. 238TCV23665, captioned Jorge Reyes v. AMVAC etc., etal., with the Superior Court for the County of Los Angeles, Central District. As is typical of this sort of action, plaintiff alleges multiple wages and hours violations, including overtime, minimum wage, sick leave, rest periods and so on. The parties attended a settlement conference on September 4, 2024, at which time they agreed to settle the matter for an amount that was within the liability recorded during the quarter ended June 30, 2024. The settlement is subject to court approval which the Company believes will be forthcoming in the first quarter of 2025. Notice of Intention to Suspend DCPA . On April 28, 2022, the USEPA published a notice of intent to suspend (“NOITS”) DCPA, the active ingredient of an herbicide marketed by the Company under the name Dacthal. The agency cited as the basis for the suspension that the Company did not take appropriate steps to provide data studies requested in support of the registration review. In fact, over the course of several years, the Company cooperated in performing the vast majority of the nearly 90 studies requested by USEPA and had been working in good faith to meet the agency’s schedule. After proceedings in law and motion, the Company entered into a settlement agreement with USEPA pursuant to which the parties set a timeline for the submission of remaining studies, which, if approved by the agency, would result in reinstatement of the registration. The Company submitted the studies in question, the agency reviewed them, and the registration was reinstated in November 2023. After that reinstatement, the agency resumed registration review, during which it expressed concern over the potential health effects on farm workers in early stages of pregnancy. These concerns arose over a comparative thyroid assay (“CTA”), a relatively new and complex study, which indicated an effect on fetal rodents. In an effort to meet the agency’s concerns, over a period of several months, the Company provided significant training to USEPA on actual use patterns for Dacthal, worker re-entry practices, size of fields treated per diem and geographical focus. Nevertheless, in April 2024, USEPA concluded that, despite the mitigation measures and other information proposed by the Company and due to its safety concerns, the agency was at an impasse in advancing its registration review of the then current label. Accordingly, out of an abundance of caution, the Company submitted a significantly narrower label and voluntarily suspended sales of Dacthal pending review and potential approval of that label. On August 6, 2024, USEPA issued an emergency order suspending all registrations of, and prohibiting all distribution, sale and use of, DCPA/Dacthal on the basis of its finding a risk of imminent harm to pregnant individuals who may be exposed to the product, based upon thyroid hormone disruption observed in prenatal rodents within a comparative thyroid assay test. While noting that the Company had attempted to address the agency’s concerns, USEPA could find no combination of practicable mitigations that would permit continued use of the product. The Company promptly implemented a program for effecting the return of product that was within the channels of trade. Further, on August 19, 2024, the Company filed notice of voluntary cancellation of DCPA products. The Company has taken charges in the amount of $ 16,191 during the three and nine months ended September 30, 2024. The charges include reported product returns from global distribution, retail and growers in the amount of $ 12,403 recorded as a reduction to net sales on the condensed consolidated statements of operations , inventory write-offs in the amount of $ 2,265 included in cost of sales on the condensed consolidated statements of operations, and logistics and disposal costs in the amount of $ 1,523 included in cost of sales on the condensed consolidated statements of operations. The corresponding liability related to the reported product returns and logistics and disposal costs in the amount of $ 13,926 is included in accrued expenses and other payables on the condensed consolidated balance sheets as of September 30, 2024.

Recent Accounting Standards

Recent Accounting Standards	9 Months Ended
Recent Accounting Standards	Sep. 30, 2024
Accounting Policies [Abstract]
Recent Accounting Standards	13. Recent Issued Accounting Guidance — In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure.” The ASU updates reportable segment disclosure requirements, primarily through requiring enhanced disclosures about significant segment expenses and information used to assess segment performance. The ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its disclosures. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The ASU includes amendments requiring enhanced income tax disclosures, primarily related to standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently evaluating the impact of adopting this ASU on its disclosures. The Company reviewed all other recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a significant impact to its condensed consolidated financial statements.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
Fair Value of Financial Instruments	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	14. Fair Value of Financial Instruments — The accounting standard for fair value measurements provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. Fair value is defined as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. This accounting standard established a fair value hierarchy, which requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required: • Level 1 – Quoted prices in active markets for identical assets or liabilities. • Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. The carrying amount of the Company’s financial instruments, which principally include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximates fair value because of the relatively short maturity of such instruments. The carrying amount of the Company’s borrowings, which are considered Level 2 liabilities, approximates fair value as they bear interest at a variable rate at current market rates.

Business Acquisitions

Business Acquisitions	9 Months Ended
Business Acquisitions	Sep. 30, 2024
Business Combinations [Abstract]
Business Acquisitions	15. Business Acquisitions — On October 5, 2023, the Company completed the acquisition of all outstanding stock of Punto Verde S.A. Punversa (Punto Verde), a well-established distributor in Guayaquil, Ecuador, to strengthen its product portfolio and market access in the Latin American region. The Company paid cash consideration of $ 4,492 , which was net of cash acquired of $ 233 . The acquisition was accounted for as a business combination and the purchase consideration was allocated as follows: Preliminary Allocation at December 31, 2023 Adjustments recorded in 2024 Final Allocation Trade receivables $ 1,883 $ — $ 1,883 Inventory and other current assets 1,330 — 1,330 Property, plant, and equipment 45 90 135 Customer relationships — 1,300 1,300 Product registrations and product rights 104 396 500 Goodwill 2,948 ( 1,339 ) 1,609 Liabilities assumed ( 1,818 ) ( 447 ) ( 2,265 ) Total $ 4,492 $ — $ 4,492 Liabilities assumed include liabilities of $ 447 related to income tax matters. Goodwill is not expected to be deductible for income tax purposes. The operating results of Punto Verde have been included in the Company's consolidated statements of operations from the date of acquisition. Pro-forma financial information is not included herein as the pro-forma impact of the acquisition is not material.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
Accumulated Other Comprehensive Loss	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss	16. Accumulated Other Comprehensive Loss — The following table lists the beginning balance, quarterly activity and ending balance of accumulated other comprehensive loss, which consists of foreign currency translation adjustments: Total Balance, January 1, 2024 $ ( 5,963 ) Foreign currency translation adjustment, net of tax effects of ($ 205 ) ( 1,564 ) Balance, March 31, 2024 ( 7,527 ) Foreign currency translation adjustment, net of tax effects of ($ 79 ) ( 5,729 ) Balance, June 30, 2024 $ ( 13,256 ) Foreign currency translation adjustment, net of tax effects of $ 159 ( 593 ) Balance, September 30, 2024 $ ( 13,849 ) Balance, January 1, 2023 $ ( 12,182 ) Foreign currency translation adjustment, net of tax effects of ($ 132 ) 2,546 Balance, March 31, 2023 ( 9,636 ) Foreign currency translation adjustment, net of tax effects of ($ 122 ) 3,505 Balance, June 30, 2023 $ ( 6,131 ) Foreign currency translation adjustment, net of tax effects of $ 133 ( 3,123 ) Balance, September 30, 2023 $ ( 9,254 )

Equity Investments

Equity Investments	9 Months Ended
Equity Investments	Sep. 30, 2024
Investments, All Other Investments [Abstract]
Equity Investment	17. Equity Investments — In February 2016, AMVAC Netherlands BV made an investment in Biological Products for Agriculture (“Bi-PA”). Bi-PA develops biological plant protection products that can be used for the control of pests and disease of agricultural crops. As of September 30, 2024 and December 31, 2023, the Company’s ownership position in Bi-PA was 15 %. Since this investment does not have readily determinable fair value, the Company has elected to measure the investment at cost less impairment, if any, and also records an increase or decrease for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of Bi-PA. The Company periodically reviews the investment for possible impairment. There was no impairment or observable price changes on the investment during the three and nine months ended September 30, 2024 and 2023. The investment is recorded within other assets on the condensed consolidated balance sheets and amounted to $ 2,869 as of September 30, 2024 and December 31, 2023. On April 1, 2020, AMVAC purchased 6.25 million shares, an ownership of approximately 8 %, of common stock of Clean Seed Capital Group Ltd. The shares were publicly traded, had a readily determinable fair value, and were considered a Level 1 investment. In Q1 2024, Clean Seed's shares temporarily ceased trading. Since this investment does not have readily determinable fair value at this time, the Company has elected to measure the investment at the last trading price less impairment, if any, and also records an increase or decrease for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of Clean Seed. The fair value of the stock amounted to $ 938 and $ 425 as of September 30, 2024 and December 31, 2023, respectively. The Company recorded a loss of $ 247 for the three months ended September 30, 2023. There was no change in value and no loss recorded in the three months ended September 30, 2024. The Company recorded a gain of $ 513 for the nine months ended September 30, 2024 and loss of $ 324 for the nine months ended September 30, 2023. The investment is recorded within other assets on the condensed consolidated balance sheets.

Product and Business Acquisitio

Product and Business Acquisitions	9 Months Ended
Product and Business Acquisitions	Sep. 30, 2024
Business Combinations [Abstract]
Business Acquisitions	15. Business Acquisitions — On October 5, 2023, the Company completed the acquisition of all outstanding stock of Punto Verde S.A. Punversa (Punto Verde), a well-established distributor in Guayaquil, Ecuador, to strengthen its product portfolio and market access in the Latin American region. The Company paid cash consideration of $ 4,492 , which was net of cash acquired of $ 233 . The acquisition was accounted for as a business combination and the purchase consideration was allocated as follows: Preliminary Allocation at December 31, 2023 Adjustments recorded in 2024 Final Allocation Trade receivables $ 1,883 $ — $ 1,883 Inventory and other current assets 1,330 — 1,330 Property, plant, and equipment 45 90 135 Customer relationships — 1,300 1,300 Product registrations and product rights 104 396 500 Goodwill 2,948 ( 1,339 ) 1,609 Liabilities assumed ( 1,818 ) ( 447 ) ( 2,265 ) Total $ 4,492 $ — $ 4,492 Liabilities assumed include liabilities of $ 447 related to income tax matters. Goodwill is not expected to be deductible for income tax purposes. The operating results of Punto Verde have been included in the Company's consolidated statements of operations from the date of acquisition. Pro-forma financial information is not included herein as the pro-forma impact of the acquisition is not material.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	18. Income Taxes — Income tax benefit was $ 7,024 for the three months ended September 30, 2024, as compared to income tax expense of $ 885 for the three-months ended September 30, 2023. Income tax benefit was $ 7,093 for the nine months ended September 30, 2024 as compared to an income tax expense of $ 2,066 for the nine months ended September 30, 2023. The effective income tax rate for the three and nine-month periods ended September 30, 2024 was computed based on the actual effective tax rate for the year-to-date period ended September 30, 2024. This calculation resulted in an effective income tax rate of 21.4 % for the three months ended September 30, 2024, as compared to 158.0 % for the three-months ended September 30, 2023. The effective income tax rate was 16.5 % for the nine months ended September 30, 2024, as compared to 79.3 %. for the nine months ended September 30, 2023. The decrease in the effective income tax rate for the three and nine months ended September 30, 2024 compared to the same periods in the prior year is primarily attributable to income tax benefits associated with transformation costs and losses before provision for income taxes incurred during the periods of 2024. It is expected that $ 328 of unrecognized tax benefits will be released within the next twelve months due to expiration of the statute of limitations.

Stock Re-purchase Program

Stock Re-purchase Program	9 Months Ended
Stock Re-purchase Program	Sep. 30, 2024
Equity [Abstract]
Stock Re-purchase Program	19. Stock Re-purchase Programs — On March 8, 2022, pursuant to a Board of Directors resolution, the Company announced its intention to repurchase an aggregate number of up to 1,000,000 shares of its common stock under a 10b5-1 plan, par value $ 0.10 per share, in the open market over the succeeding one year, subject to limitations and restrictions under applicable securities laws. On May 25, 2023, pursuant to a Board of Directors resolution, the Company announced its intention to repurchase up to $ 15,000 of its common stock under a 10b5-1 plan, par value $ 0.10 per share, in the open market over the succeeding one year, subject to limitations and restrictions under applicable securities laws. The table below summarizes the number of shares of the Company’s common stock that were repurchased during the three and nine months ended September 30, 2024 and 2023. Three months ended Total number of Average price paid Total amount paid September 30, 2024 — — $ — September 30, 2023 477,089 $ 17.42 $ 8,313 Nine months ended Total number of Average price paid Total amount paid September 30, 2024 — — $ — September 30, 2023 885,290 $ 17.55 $ 15,539 Pursuant to Amendments Number Six and Seven to the Third Amended Loan and Security Agreement, the Company is currently prevented from making stock repurchases, effective November 7, 2023 .

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
Supplemental Cash Flow Information	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Cash Flow Information	20. Supplemental Cash Flow Information For the Nine Months Ended September 30, 2024 2023 Supplemental cash flow information: Cash paid during the period for: Interest $ 11,833 $ 7,317 Income taxes, net of refunds $ 8,150 $ 7,643 Non-cash transactions: Cash dividends declared and included in accrued expenses $ — $ 834

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Transformation	Transformation Transformation expenses on the condensed consolidated statements of operations include costs related to the Company’s digital and structural transformation project. The digital transformation effort is intended to ensure that business process owners have access to current and complete data that has been generated through standardized systems and processes. The structural transformation effort is intended to improve operating leverage by applying business analytics to current operations, structures, products and services and identifying process improvements. Transformation expenses primarily include costs for consulting services, severance costs, and other costs which were incurred in connection with the staffing and execution of the Company’s various transformation initiatives

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Sep. 30, 2024
Leases [Abstract]
Schedule of Other Information of Operating Leases	Other information related to operating leases follows: Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cash paid for amounts included in the $ 1,956 $ 1,601 $ 5,909 $ 4,788 ROU assets obtained in exchange for $ 541 $ 643 $ 4,211 $ 3,220
Schedule of Weighted-Average Remaining Lease Term and Discount Rate Related to Operating Leases	The weighted-average remaining lease term and discount rate related to the operating leases as of September 30, 2024 were as follows: Weighted-average remaining lease term (in years) 4.55 Weighted-average discount rate 4.94 %
Schedule of Future Minimum Lease Payments Under Non-Cancellable Operating Leases	Future minimum lease payments under non-cancellable operating leases as of September 30, 2024 were as follows: 2024 (excluding nine months ended September 30, 2024) $ 1,950 2025 7,078 2026 5,202 2027 3,451 2028 2,339 Thereafter 4,676 Total lease payments 24,696 Less: imputed interest ( 2,518 ) Total $ 22,178 Amounts recognized in the condensed consolidated balance sheets at September 30, 2024: Operating lease liabilities, current $ 6,604 Operating lease liabilities, long-term $ 15,574

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
Revenue Recognition (Tables)	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Summary of Selective Enterprise Information of Sales Disaggregated By Category and Geographic Region	Selective enterprise information of sales disaggregated by category and geographic region is as follows: For the Three Months Ended September 30, 2024 2023 Change % Change Net sales: U.S. crop $ 35,533 $ 67,749 $ ( 32,216 ) - 48 % U.S. non-crop 22,454 19,250 3,204 17 % Total U.S. 57,987 86,999 ( 29,012 ) - 33 % International 60,320 62,517 ( 2,197 ) - 4 % Total net sales $ 118,307 $ 149,516 $ ( 31,209 ) - 21 % For the Nine Months Ended September 30, 2024 2023 Change % Change Net sales: U.S. crop $ 155,075 $ 185,823 $ ( 30,748 ) - 17 % U.S. non-crop 59,241 50,041 9,200 18 % Total U.S. 214,316 235,864 ( 21,548 ) - 9 % International 167,343 171,327 ( 3,984 ) - 2 % Total net sales $ 381,659 $ 407,191 $ ( 25,532 ) - 6 %

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
Property, Plant and Equipment (Tables)	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment at September 30, 2024 and December 31, 2023 consists of the following: September 30, December 31, 2023 Land $ 2,757 $ 2,765 Buildings and improvements 21,131 21,088 Machinery and equipment 155,633 148,912 Office furniture, fixtures and equipment 12,529 10,622 Automotive equipment 1,043 1,247 Construction in progress 6,505 10,553 Total gross value 199,598 195,187 Less accumulated depreciation ( 126,104 ) ( 120,627 ) Total net value $ 73,494 $ 74,560

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Sep. 30, 2024
Inventory Disclosure [Abstract]
Components of Inventories	September 30, December 31, 2023 Finished products $ 201,227 $ 198,935 Raw materials 44,810 20,616 Total inventories $ 246,037 $ 219,551

Cash Dividends on Common Stock

Cash Dividends on Common Stock (Tables)	9 Months Ended
Cash Dividends on Common Stock (Tables)	Sep. 30, 2024
Cash Dividends [Abstract]
Scheduel of Cash Dividends on Common Stock	The Company has declared and paid the following cash dividends in the periods covered by this Form 10-Q: Declaration Date Record Date Distribution Date Dividend Total June 10, 2024 June 26, 2024 July 10, 2024 $ 0.030 $ 840 March 11, 2024 March 27, 2024 April 10, 2024 $ 0.030 $ 836 December 15, 2023 December 29, 2023 January 12, 2024 $ 0.030 $ 834 September 12, 2023 September 22, 2023 October 6, 2023 $ 0.030 $ 834 June 12, 2023 June 28, 2023 July 14, 2023 $ 0.030 $ 848 March 13, 2023 March 24, 2023 April 14, 2023 $ 0.030 $ 851 December 13, 2022 December 28, 2022 January 11, 2023 $ 0.030 $ 851

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
Earnings Per Share (Tables)	Sep. 30, 2024
Earnings Per Share [Abstract]
Components of Basic and Diluted Earnings Per Share	The components of basic and diluted net (loss) income per share were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net (loss) income $ ( 25,742 ) $ ( 325 ) $ ( 35,911 ) $ 540 Denominator: (in thousands) Weighted average shares outstanding-basic 28,173 27,919 28,015 28,236 Dilutive effect of stock options and grants — — — 420 Weighted average shares outstanding-diluted 28,173 27,919 28,015 28,656

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2024
Debt Disclosure [Abstract]
Summary of Revolving Line of Credit	The debt is summarized in the following table: Long-term indebtedness ($000's) September 30, 2024 December 31, 2023 Revolving line of credit $ 178,749 $ 138,900 Deferred loan fees ( 1,726 ) ( 1,218 ) Total indebtedness, net of deferred loan fees $ 177,023 $ 137,682

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
Stock Based Compensation (Tables)	Sep. 30, 2024
Schedule of Time-based Incentive Stock Option Activity	A summary of the time-based incentive stock option activity for the nine months ended September 30, 2024 is presented below: Options outstanding Weighted Average Exercise Price Per Share Weighted Average Remaining Contractual Life (Years) Aggregate Intrinsic Value Balance as of January 1, 2024 146,680 $ 11.49 1.0 $ — Granted 680,737 $ 10.29 6.3 $ — Forfeited ( 232,229 ) $ 10.32 6.3 $ — Balance as of September 30, 2024 595,188 $ 10.58 5.6 $ — Options vested and exercisable as of September 30, 2024 203,542 $ 11.15 1.9 $ —
Restricted and Unrestricted Stock
Summary of Non-Vested Shares	A summary of nonvested RSUs outstanding is presented below: Nine Months Ended Number Weighted Nonvested shares at January 1, 2024 949,510 $ 21.28 Granted 58,573 10.39 Vested ( 403,038 ) 20.40 Forfeited ( 178,338 ) 20.05 Nonvested shares at September 30, 2024 426,707 $ 21.13

Business Acquisitions (Tables)

Business Acquisitions (Tables)	9 Months Ended
Business Acquisitions (Tables)	Sep. 30, 2024
Business Combinations [Abstract]
Summary of Allocated of Business Combination And The Purchase Consideration	The acquisition was accounted for as a business combination and the purchase consideration was allocated as follows: Preliminary Allocation at December 31, 2023 Adjustments recorded in 2024 Final Allocation Trade receivables $ 1,883 $ — $ 1,883 Inventory and other current assets 1,330 — 1,330 Property, plant, and equipment 45 90 135 Customer relationships — 1,300 1,300 Product registrations and product rights 104 396 500 Goodwill 2,948 ( 1,339 ) 1,609 Liabilities assumed ( 1,818 ) ( 447 ) ( 2,265 ) Total $ 4,492 $ — $ 4,492

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Sep. 30, 2024
Equity [Abstract]
Beginning Balance, Quarterly Activity and Ending Balance of Foreign Currency Translation Adjustment Included as Component of Accumulated Other Comprehensive Loss	The following table lists the beginning balance, quarterly activity and ending balance of accumulated other comprehensive loss, which consists of foreign currency translation adjustments: Total Balance, January 1, 2024 $ ( 5,963 ) Foreign currency translation adjustment, net of tax effects of ($ 205 ) ( 1,564 ) Balance, March 31, 2024 ( 7,527 ) Foreign currency translation adjustment, net of tax effects of ($ 79 ) ( 5,729 ) Balance, June 30, 2024 $ ( 13,256 ) Foreign currency translation adjustment, net of tax effects of $ 159 ( 593 ) Balance, September 30, 2024 $ ( 13,849 ) Balance, January 1, 2023 $ ( 12,182 ) Foreign currency translation adjustment, net of tax effects of ($ 132 ) 2,546 Balance, March 31, 2023 ( 9,636 ) Foreign currency translation adjustment, net of tax effects of ($ 122 ) 3,505 Balance, June 30, 2023 $ ( 6,131 ) Foreign currency translation adjustment, net of tax effects of $ 133 ( 3,123 ) Balance, September 30, 2023 $ ( 9,254 )

Stock Re-purchase Program (Tabl

Stock Re-purchase Program (Tables)	9 Months Ended
Stock Re-purchase Program (Tables)	Sep. 30, 2024
Equity, Class of Treasury Stock [Line Items]
Summary of Number of Shares of Common Stock Repurchased	The table below summarizes the number of shares of the Company’s common stock that were repurchased during the three and nine months ended September 30, 2024 and 2023. Three months ended Total number of Average price paid Total amount paid September 30, 2024 — — $ — September 30, 2023 477,089 $ 17.42 $ 8,313 Nine months ended Total number of Average price paid Total amount paid September 30, 2024 — — $ — September 30, 2023 885,290 $ 17.55 $ 15,539

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
Supplemental Cash Flow Information (Tables)	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule Of Supplemental Cash Flow Information	For the Nine Months Ended September 30, 2024 2023 Supplemental cash flow information: Cash paid during the period for: Interest $ 11,833 $ 7,317 Income taxes, net of refunds $ 8,150 $ 7,643 Non-cash transactions: Cash dividends declared and included in accrued expenses $ — $ 834

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Leases [Line Items]
Operating lease expenses	$ 1,972	$ 1,701	$ 5,863	$ 5,012
Minimum
Leases [Line Items]
Operating lease term	1 year		1 year
Maximum
Leases [Line Items]
Operating lease term	20 years		20 years

Leases - Schedule of Additional

Leases - Schedule of Additional Information of Operating Leases (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 1,956	$ 1,601	$ 5,909	$ 4,788
ROU assets obtained in exchange for new liabilities	$ 541	$ 643	$ 4,211	$ 3,220

Leases - Schedule of Weighted-A

Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate Related to Operating Leases (Detail)	Sep. 30, 2024
Leases [Abstract]
Weighted-average remaining lease term (in years)	4 years 6 months 18 days
Weighted-average discount rate	4.94%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments Under Non-Cancellable Operating Leases (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Leases [Abstract]
2024 (excluding nine months ended September 30, 2024)	$ 1,950
2025	7,078
2026	5,202
2027	3,451
2028	2,339
Thereafter	4,676
Total lease payments	24,696
Less: imputed interest	(2,518)
Total	22,178
Amounts recognized in the condensed consolidated balance sheets:
Operating lease liabilities, current	6,604	$ 6,081
Operating lease liabilities, long-term	$ 15,574	$ 17,113

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Disaggregation Of Revenue [Line Items]
Revenue recognized	$ 12,042	$ 65,512
Customer Refunds	48
US
Disaggregation Of Revenue [Line Items]
Revenue recognized	57,000
Reversed revenue	$ 11,783
International
Disaggregation Of Revenue [Line Items]
Reversed revenue		$ 620

Revenue Recognition - Summary o

Revenue Recognition - Summary of Selective Enterprise Information of Sales Disaggregated By Category and Geographic Region (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation Of Revenue [Line Items]
Net sales	$ 118,307	$ 149,516	$ 381,659	$ 407,191
Change in net sales	$ (31,209)		$ (25,532)
Change in net sales (%)	(21.00%)		(6.00%)
US
Disaggregation Of Revenue [Line Items]
Net sales	$ 57,987	86,999	$ 214,316	235,864
Change in net sales	$ (29,012)		$ (21,548)
Change in net sales (%)	(33.00%)		(9.00%)
US \| Crop
Disaggregation Of Revenue [Line Items]
Net sales	$ 35,533	67,749	$ 155,075	185,823
Change in net sales	$ (32,216)		$ (30,748)
Change in net sales (%)	(48.00%)		(17.00%)
US \| Non-Crop
Disaggregation Of Revenue [Line Items]
Net sales	$ 22,454	19,250	$ 59,241	50,041
Change in net sales	$ 3,204		$ 9,200
Change in net sales (%)	17%		18%
International
Disaggregation Of Revenue [Line Items]
Net sales	$ 60,320	$ 62,517	$ 167,343	$ 171,327
Change in net sales	$ (2,197)		$ (3,984)
Change in net sales (%)	(4.00%)		(2.00%)

Summary of Property, Plant and

Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total gross value	$ 199,598	$ 195,187
Less accumulated depreciation	(126,104)	(120,627)
Total net value	73,494	74,560
Land
Property, Plant and Equipment [Line Items]
Total gross value	2,757	2,765
Buildings and improvements
Property, Plant and Equipment [Line Items]
Total gross value	21,131	21,088
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total gross value	155,633	148,912
Office furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Total gross value	12,529	10,622
Automotive equipment
Property, Plant and Equipment [Line Items]
Total gross value	1,043	1,247
Construction in progress
Property, Plant and Equipment [Line Items]
Total gross value	$ 6,505	$ 10,553

Property, Plant And Equipment -

Property, Plant And Equipment - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense related to property, plant and equipment	$ 2,290	$ 2,074	$ 6,655	$ 6,396

Components of Inventories (Deta

Components of Inventories (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Finished products	$ 201,227	$ 198,935
Raw materials	44,810	20,616
Total inventories	$ 246,037	$ 219,551

Summary of Business Sales by Pr

Summary of Business Sales by Product and Geographic Location (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net sales
Net sales	$ 118,307	$ 149,516	$ 381,659	$ 407,191
Gross profit:
Gross profit	17,293	43,084	97,474	124,529
US
Net sales
Net sales	57,987	86,999	214,316	235,864
US \| Crop
Net sales
Net sales	35,533	67,749	155,075	185,823
US \| Non-Crop
Net sales
Net sales	22,454	19,250	59,241	50,041
International
Net sales
Net sales	$ 60,320	$ 62,517	$ 167,343	$ 171,327

Cash Dividends on Common Stoc_2

Cash Dividends on Common Stock (Detail) - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended	12 Months Ended
Cash Dividends on Common Stock (Detail) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
O 2024 Q2 Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date			Jun. 10, 2024
Cash dividend record date			Jun. 26, 2024
Cash dividend distributed date			Jul. 10, 2024
Cash dividend per share			$ 0.03
Cash dividend paid			$ 840,000
O 2024 Q1 Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date	Mar. 11, 2024
Cash dividend record date	Mar. 27, 2024
Cash dividend distributed date	Apr. 10, 2024
Cash dividend per share	$ 0.03
Cash dividend paid	$ 836,000
O 2023 A Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date						Dec. 15, 2023
Cash dividend record date						Dec. 29, 2023
Cash dividend distributed date						Jan. 12, 2024
Cash dividend per share						$ 0.03
Cash dividend paid						$ 834,000
O 2022 A Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date							Dec. 13, 2022
Cash dividend record date							Dec. 28, 2022
Cash dividend distributed date							Jan. 11, 2023
Cash dividend per share							$ 0.03
Cash dividend paid							$ 851,000
O 2023 Q1 Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date		Mar. 13, 2023
Cash dividend record date		Mar. 24, 2023
Cash dividend distributed date		Apr. 14, 2023
Cash dividend per share		$ 0.03
Cash dividend paid		$ 851,000
O 2023 Q2 Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date				Jun. 12, 2023
Cash dividend record date				Jun. 28, 2023
Cash dividend distributed date				Jul. 14, 2023
Cash dividend per share				$ 0.03
Cash dividend paid				$ 848,000
O 2023 Q3 Dividends [Member]
Dividends Payable [Line Items]
Cash dividend declaration date					Sep. 12, 2023
Cash dividend record date					Sep. 22, 2023
Cash dividend distributed date					Oct. 06, 2023
Cash dividend per share					$ 0.03
Cash dividend paid					$ 834

Earnings Per Share - Components

Earnings Per Share - Components of Basic and Diluted Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net (loss) income	$ (25,742)	$ (325)	$ (35,911)	$ 540
Denominator: (in thousands)
Weighted average shares outstanding-basic	28,173	27,919	28,015	28,236
Dilutive effect of stock options and grants	0	0	0	420
Weighted average shares outstanding-diluted	28,173	27,919	28,015	28,656

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) shares in Thousands	9 Months Ended
	Sep. 30, 2023 shares
Earnings Per Share [Abstract]
Stock options excluded from computation of diluted earning per share	0

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Short term debt	$ 0		$ 0		$ 0
Credit agreement, Interest	4,378	$ 3,384	$ 11,988	$ 8,282
LIBOR Member
Debt Instrument [Line Items]
Credit agreement, variable rate basis			1%
Amendment Credit Agreement [Member]
Debt Instrument [Line Items]
Credit agreement, variable rate description			the Company and the lenders entered into Amendment Number Seven to the Credit Agreement, effective June 30, 2024, under which the Maximum Total Leverage Ratio was modified to 4.25 for the period ended June 30, 2024; 5.0 for the period ending September 30, 2024; 4.5 for the periods ending December 31, 2024, March 31, 2025 and 4.25 for June 30, 2025; 4.0 for the period ending September 30, 2025, and returning to 3.25 for the period ending December 31, 2025 and thereafter. The Minimum Fixed Charge Coverage Ratio remains the same, and a new covenant, the Minimum Modified Current Ratio of not less than 1.5 (defined as the ratio of (i) Accounts Receivable plus Inventory, to (ii) Funded Debt of the Company and its Subsidiaries on a consolidated basis). In addition, the Company may not repurchase shares, pay cash dividends to shareholders or make Permitted Acquisitions without Lenders’ consent. In addition, for purposes of calculating Consolidated EBITDA, the basket for transformation and one-time (cash and non-cash charges (which are excluded from such measure) has been increased from $5,000 to $12,500 in second quarter 2024, $45,000 (in third quarter 2024, fourth quarter 2024 and first quarter 2025), $42,500 in second quarter 2025, $15,000 in third quarter 2025 and $7,500 in fourth quarter 2025, as measured on a four-quarter trailing basis. Finally, the interest rates for the Credit Agreement, as amended, were increased by 25bps to the extent the Total Leverage Ratio equals or exceeds 4.0 and remains at the rates set forth in the Amendment Number Six to the extent the Total Leverage Ratio is below 4.0
Amendment Credit Agreement [Member] \| Q2 2024 [Member]
Debt Instrument [Line Items]
Credit agreement, variable rate basis			4%
Senior Secured Revolving Line of Credit
Debt Instrument [Line Items]
Aggregate principal amount	$ 275,000		$ 275,000
Credit agreement, covenant description			the Credit Agreement originally contained two: namely, borrowers are required to maintain a Total Leverage Ratio of no more than 3.5-to-1, during the first three years, stepping down to 3.25-to-1 as of September 30, 2024, and a Fixed Charge Coverage Ratio of at least 1.25-to-1. In addition, to the extent that it completes acquisitions totaling $15,000 or more in any 90-day period, AMVAC may step-up the Total Leverage Ratio by 0.5-to-1, not to exceed 4.00-to-1, for the next three full consecutive quarters.
Consolidated funded debt ratio			3.25%
Senior secured credit facility, maturity date			Aug. 05, 2026
Credit agreement, variable rate description			Under the Credit Agreement, revolving loans bear interest at a variable rate based, at borrower’s election with proper notice, on either (i) LIBOR plus the “Applicable Margin” which is based upon the Total Leverage Ratio (“LIBOR Revolver Loan”) or (ii) the greater of (x) the Prime Rate, (y) the Federal Funds Rate plus 0.5%, and (z) the Daily One-Month LIBOR Rate plus 1.00%, plus, in the case of (x), (y) or (z) the Applicable Margin (“Adjusted Base Rate Revolver Loan”). The Company and the Lenders entered into an amendment to the Credit Agreement, effective March 9, 2023, whereby LIBOR was replaced by SOFR with a credit spread adjustment of 10.0 bps for all SOFR periods. The revolving loans now bear interest at a variable rate based at our election with proper notice, on either (i) SOFR plus 0.1% per annum and the “Applicable Margin” or (ii) the greater of (x) the Prime Rate, (y) the Federal Funds Rate plus 0.5%, and (z) the Daily One-Month SOFR Rate plus 1.10%, plus, in the case of (x), (y) or (z) the Applicable Margin (“Adjusted Base Rate Revolver Loan”). Interest payments for SOFR Revolver Loans are payable on the last day of each interest period (either one-, three- or nine- month periods, as selected by the Company)
Debt Instrument, Interest Rate, Stated Percentage	8.48%		8.48%
Interest Expense, Debt	$ 4,435	$ 3,384	$ 12,296	$ 8,282
Senior Secured Revolving Line of Credit \| Federal Funds Rate
Debt Instrument [Line Items]
Credit agreement, variable rate basis			0.50%
Senior Secured Revolving Line of Credit \| LIBOR Member
Debt Instrument [Line Items]
Credit agreement, variable rate basis			1.10%
Senior Secured Revolving Line of Credit \| Adjusted Base Rate
Debt Instrument [Line Items]
Credit agreement, interest payment period, description			last business day of each month and the maturity date.
Senior Secured Revolving Line of Credit \| Term Loan [Member]
Debt Instrument [Line Items]
Accordion feature	150,000		$ 150,000
Senior Secured Revolving Line of Credit \| Credit Agreement [Member]
Debt Instrument [Line Items]
Consolidated funded debt ratio			0.50%
Maximum \| Senior Secured Revolving Line of Credit
Debt Instrument [Line Items]
Available borrowings capacity under credit agreement	25,000		$ 25,000
Consolidated funded debt ratio			3.50%
Maximum \| Senior Secured Revolving Line of Credit \| Credit Agreement [Member]
Debt Instrument [Line Items]
Consolidated funded debt ratio			4%
Joint venture, consideration			$ 50,000
Capacity to increase borrowings under credit agreement	$ 44,716		$ 44,716		$ 115,002
Minimum \| Senior Secured Revolving Line of Credit
Debt Instrument [Line Items]
Consolidated fixed charge covenant ratio			1.25%
Minimum \| Senior Secured Revolving Line of Credit \| Credit Agreement [Member]
Debt Instrument [Line Items]
Joint venture, consideration			$ 15,000

Debt - Summary of Revolving Lin

Debt - Summary of Revolving Line of Credit (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Revolving line of credit	$ 178,749	$ 138,900
Deferred loan fees	(1,726)	(1,218)
Total indebtedness, net of deferred loan fees	$ 177,023	$ 137,682

Change in Accounting Principle

Change in Accounting Principle - Schedule of classification after the adoption of the change in accounting (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net sales	$ 118,307	$ 149,516	$ 381,659	$ 407,191
Cost of Revenue, Total	101,014	106,432	284,185	282,662
Gross profit	$ 17,293	$ 43,084	$ 97,474	$ 124,529

Unamortized Stock-Based Compens

Unamortized Stock-Based Compensation Expenses (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation	$ 3,887	$ 4,257

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Non-Vested Shares (Detail) - Restricted and Unrestricted Stock	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Beginning balance \| shares	949,510
Number of Shares, Granted \| shares	58,573
Number of Shares, Vested \| shares	(403,038)
Number of Shares, Forfeited \| shares	(178,338)
Number of Shares, Ending Balance \| shares	426,707
Weighted Average Grant-Date Fair Value, Beginning balance \| $ / shares	$ 21.28
Weighted Average Grant-Date Fair Value, Granted \| $ / shares	10.39
Weighted Average Grant-Date Fair Value, Vested \| $ / shares	20.4
Weighted Average Grant-Date Fair Value, Forfeited \| $ / shares	20.05
Weighted Average Grant-Date Fair Value, Ending balance \| $ / shares	$ 21.13

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Time-based Incentive Stock Option Activity (Detail) - Time Based Incentive Stock Option [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive Stock Option Plans, Beginning balance	146,680
Incentive Stock Option Plan, Options Granted	680,737
Incentive Stock Option Plan, Options Forfeited	(232,229)
Incentive Stock Option Plans, Ending balance	595,188	146,680
Incentive Stock Option Plan, Options vested and exercisable as of June 30, 2024	203,542
Weighted Average Price Per Share, Beginning balance	$ 11.49
Weighted Average Exercise Price Per Share, Granted	10.29
Weighted Average Exercise Price Per Share, Forfeited	10.32
Weighted Average Price Per Share, Ending balance	10.58	$ 11.49
Weighted Average Exercise Price Per Share, Options vested and exercisable as of June 30, 2024	$ 11.15
Weighted Average Remaining Contractual Life, Outstanding	5 years 7 months 6 days	1 year
Weighted Average Remaining Contractual Life, Granted	6 years 3 months 18 days
Weighted Average Remaining Contractual Life, Forfrited	6 years 3 months 18 days
Weighted Average Remaining Contractual Life, Options vested and exercisable as of June 30, 2024	1 year 10 months 24 days

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 1,135	$ 1,716	$ 3,887	$ 4,257
Incentive Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	1,209		$ 1,209
Remaining Weighted Average Period (years)			2 years 3 months 18 days
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 3,278		$ 3,278
Remaining Weighted Average Period (years)			1 year 3 months 18 days

Business Acquisitions - Additio

Business Acquisitions - Additional Information (Detail) - Punto Verde Company [Member] $ in Thousands	Oct. 05, 2023 USD ($)
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 4,492
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	233
Liabilities assumed	$ 447

Business Acquisitions - Schedul

Business Acquisitions - Schedule of Purchase Consideration (Details) - Punto Verde Company [Member] - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Oct. 05, 2023
Business Acquisition [Line Items]
Liabilities assumed			$ 447
Preliminary Allocation [Member]
Business Acquisition [Line Items]
Trade receivables		$ 1,883
Inventory and other current assets		1,330
Property, plant, and equipment		45
Customer relationships		0
Product registrations and product rights		104
Goodwill		2,948
Liabilities assumed		(1,818)
Total		$ 4,492
Adjustments Recorded [Member]
Business Acquisition [Line Items]
Trade receivables	$ 0
Inventory and other current assets	0
Property, plant, and equipment	90
Customer relationships	1,300
Product registrations and product rights	396
Goodwill	(1,339)
Liabilities assumed	(447)
Total	0
Final Allocation [Member]
Business Acquisition [Line Items]
Trade receivables	1,883
Inventory and other current assets	1,330
Property, plant, and equipment	135
Customer relationships	1,300
Product registrations and product rights	500
Goodwill	1,609
Liabilities assumed	(2,265)
Total	$ 4,492

Beginning Balance, Quarterly Ac

Beginning Balance, Quarterly Activity and Ending Balance of Foreign Currency Translation Adjustment Included as Component of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance	$ 353,225	$ 371,583	$ 370,010	$ 369,075	$ 374,994	$ 369,979	$ 370,010	$ 369,979
Foreign currency translation adjustment, net of tax effects	(593)	(5,729)	(1,564)	(3,123)	3,505	2,546	(7,886)	2,928
Balance	327,908	353,225	371,583	358,701	369,075	374,994	327,908	358,701
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance	(13,256)	(7,527)	(5,963)	(6,131)	(9,636)	(12,182)	(5,963)	(12,182)
Foreign currency translation adjustment, net of tax effects	(593)	(5,729)	(1,564)	(3,123)	3,505	2,546
Balance	$ (13,849)	$ (13,256)	$ (7,527)	$ (9,254)	$ (6,131)	$ (9,636)	$ (13,849)	$ (9,254)

Beginning Balance, Quarterly _2

Beginning Balance, Quarterly Activity and Ending Balance of Foreign Currency Translation Adjustment Included as Component of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Equity [Abstract]
Foreign currency translation adjustment, tax effect	$ 159	$ (79)	$ (205)	$ 133	$ (122)	$ (132)

Equity Investment - Additional

Equity Investment - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
	Apr. 01, 2020	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items]
Gain (loss) from equity method investment		$ 0	$ (247)	$ 513	$ (324)
Bi Pa
Schedule Of Equity Method Investments [Line Items]
Cost method ownership percentage		15%		15%		15%
Impairment Of Investment		$ 0	0	$ 0	0
Investments value		2,869		2,869		$ 2,869
Clean Seed Capital Group Ltd
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment Shares Purchased	6,250
Equity investment ownership position	8%
Fair value of stock		938		938		$ 425
Loss on equity method investment		$ 0	$ (247)	$ 513	$ (324)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax benefit (expense)	$ 7,024	$ (885)	$ 7,093	$ (2,066)
Federal income tax rate	(21.40%)	(158.00%)	(16.50%)	(79.30%)
Unrecognized tax benefits	$ 328		$ 328

Stock Re-purchase Program - Add

Stock Re-purchase Program - Additional Information (Detail) - USD ($)			3 Months Ended		9 Months Ended
	May 25, 2023	Mar. 08, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Equity Class Of Treasury Stock [Line Items]
Common stock, par value per share			$ 0.10		$ 0.10		$ 0.10
Repurchase of common stock					$ 0	$ 15,539,000
Common Stock
Equity Class Of Treasury Stock [Line Items]
Number of shares purchased		1,000,000	0	477,089	0	885,290
Common stock, par value per share		$ 0.1
Common Stock \| ASR [Member] \| Open Market Transactions [Member]
Equity Class Of Treasury Stock [Line Items]
Common stock, par value per share	$ 0.1
Common Stock \| Board of Directors \| ASR [Member] \| Open Market Transactions [Member]
Equity Class Of Treasury Stock [Line Items]
Repurchase of common stock	$ 15,000

Stock Re-purchase Programs - Su

Stock Re-purchase Programs - Summary of Number of Shares of Common Stock Repurchased (Detail) - Common Stock - USD ($)		3 Months Ended		9 Months Ended
	Mar. 08, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Equity Class Of Treasury Stock [Line Items]
Number of shares purchased	1,000,000	0	477,089	0	885,290
Average price paid per share		$ 0	$ 17.42	$ 0	$ 17.55
Total amount paid		$ 0	$ 8,313	$ 0	$ 15,539

Commitments and Contingencies (

Commitments and Contingencies (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Loss Contingencies [Line Items]
Voluntary Cancellation of DCPA Products	$ 16,191	$ 16,191
Charges include Reported Product Returns	12,403
Inventory Write-offs, Logistics and Disposal Costs	2,265
Logistics and disposal costs	$ 1,523	$ 13,926

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Schedule Of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Supplemental Cash Flow Information [Abstract]
Interest	$ 11,833	$ 7,317
Income taxes, net of refunds	8,150	7,643
Non-cash transactions:
Cash dividends declared and included in accrued expenses	$ 0	$ 834